| Date Filed | Type | Description |
| 10/31/2022 |
SC 13D
| Audentes Therapeutics, Inc. reports a 11.6% stake in TAYSHA GENE THERAPIES, INC. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8% stake in Audentes Therapeutics, Inc. |
| 01/27/2020 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/21/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/21/2020 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 01/15/2020 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 01/15/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/15/2020 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 01/15/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/15/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/15/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/15/2020 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/15/2020 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 01/15/2020 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
| 01/15/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/15/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/07/2020 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 01/07/2020 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 01/07/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 1.4% stake in Audentes Therapeutics, Inc. |
| 12/27/2019 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 12/27/2019 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 12/21/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – BOLD, INST, THOR |
| 12/16/2019 |
GN
| TECD, TIF, BOLD, and WLH SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts |
| 12/16/2019 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 12/16/2019 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 12/16/2019 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 12/10/2019 |
GN
| SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders – INST, AKS, BOLD, SORL |
| 12/09/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/04/2019 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 12/02/2019 |
GN
| Audentes Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Audentes Therapeutics, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – BOLD |
|